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Abstract
Background: The purpose of this research was to explore women's decision-making experiences
related to the option of risk-reducing mastectomy (RM), using a case series of three women who
are carriers of a BRCA1/2 gene mutation.
Methods:  Data was collected in a pilot study that assessed the response of women to an
information booklet about RM and decision-making support strategies. A detailed analysis of three
women's descriptions of their decision-making processes and outcomes was conducted.
Results: All three women were carriers of a BRCA1/2 gene mutation and, although undecided,
were leaning towards RM when initially assessed. Each woman reported a different RM decision
outcome at last follow-up. Case #1 decided not to have RM, stating that RM was "too radical" and
early detection methods were an effective strategy for dealing with breast cancer risk. Case #2
remained undecided about RM and, over time, she became less prepared to make a decision
because she felt she did not have sufficient information about surgical effects. Case #3 had
undergone RM by the time of her second follow-up interview and reported that she felt "a load off
(her) mind now".
Conclusion: RM decision making may shift over time and require decision support over an
extended period.
Background
As testing for BRCA1/2  gene mutations becomes more
widely available as a clinical service, increasing numbers
of women are being identified at high risk for breast and
ovarian cancer. Female BRCA1/2  carriers are told they
have an estimated lifetime risk of breast cancer between
50% and 85% [1]. Risk-reducing mastectomy (RM) is one
option for breast cancer risk reduction that is offered to
women who learn they are carriers of a BRCA1/2 gene
mutation. Although reported interest in RM varies by
clinic setting and country, up to half of women at high risk
for breast cancer express either the intention to have RM
or some uncertainty about this decision [2-4]. Our clinical
observations indicate that with increased access to
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BRCA1/2 genetic testing, more high-risk women are con-
sidering RM and the majority of these women request
additional information and support with this difficult
decision.
An emerging body of research describes high-risk
women's experiences and satisfaction with RM [5]. In one
of the first long-term studies of the psychological impact
of carrying a BRCA1/2 mutation and risk-reducing sur-
gery, women reported adverse consequences of RM (i.e.,
changes in sexual function and body image), although the
majority of the women believed the benefits of decreased
fear outweighed the negative outcomes they experienced
[6]. Another recent study found that half of women who
had RM experienced ongoing physical problems up to 18
months following their surgeries [7]. Re-operations have
also been reported as common following RM with
implant reconstruction, usually for implant-related issues
[8]. Bresser et al. and Metcalfe et al. explored satisfaction
with RM and subsequent breast reconstruction with simi-
lar results; women were satisfied overall, with a significant
number reporting post-operative complications [9,10].
Women's satisfaction with decision making specific to
breast cancer risk-reducing strategies has been shown to
be enhanced with the use of decision aids or a tailored
decisional support system [11,12]. However, there are rel-
atively few studies that have assessed high-risk women's
actual decision-making processes related to breast cancer
risk management.
Although high-risk women may receive clinical recom-
mendations about prophylactic oophorectomy, chemo-
prevention, and breast screening, most clinicians are
much less directive about RM and encourage women to
make their own decisions. Because of the highly personal
nature of this decision, most health care providers attempt
to support women's decision making about RM rather
than make recommendations for or against surgery. The
decision-making process related to RM is complex
because of the individual nature of the decision, and the
implications that RM holds for women's body image are
not well understood. Women experience uncertainty and
ambivalence about RM [13,14] and health care providers
may be unsure about how best to support women's RM
decision-making. Among the many decisions faced by
women at high risk for breast cancer, decision making
related to RM is significant because asymptomatic women
are considering an irreversible surgical procedure that has
the potential to impact their physical and emotional well-
being for the rest of their lives.
The purpose of this research was to explore women's deci-
sion-making experiences related to the option of RM,
using a case series of three women who are carriers of a
BRCA1/2 gene mutation. Three cases with different deci-
sion outcomes were selected to explore the complexity of
the decision-making process, and the manner in which
women deliberated over and revisited their decisions
before resolving their treatment choices.
Methods
Data were collected in a pilot study that assessed the
response of women to a decision-making intervention
related to RM. Because of the exploratory nature of the
study, a mixed-methods approach was used that included
standardized measures as well as open-ended interview
questions to fully capture women's experiences.
The study explored high-risk women's decision-making
processes in order to guide efforts to provide decision sup-
port about RM. Eligibility criteria for the pilot study
included: 1) being at high risk for hereditary breast cancer;
2) requesting assistance from the provincial Hereditary
Cancer Program with decision making about RM; 3) did
not have breast cancer; 4) were over 18 years of age; and
5) spoke and read English. Ethics approval was granted by
institutional ethical review boards and all participants
gave informed consent.
Following baseline data collection, participants received a
booklet describing RM developed by the research team.
The booklet included available evidence related to
expected benefits and potential risks associated with RM,
and a worksheet to guide decision making. Women were
offered a follow-up consultation either by telephone or in
person with one of the co-investigators, a hereditary can-
cer nurse educator (MM). We contacted women by phone
on two occasions following the consultation to collect
data about their decision-making process. Question-
naires, developed by the investigative team, were admin-
istered to participants at baseline, and approximately two
and six months after their consultation. The question-
naires measured self-perceived knowledge of breast cancer
screening and RM, factual knowledge of breast cancer and
RM, breast cancer worry, mood state, decision conflict,
decision confidence, degree of satisfaction with the RM
decision support booklet, as well as family cancer history.
The measures that are reported on are defined below Table
1. The final telephone contact also included a semi-struc-
tured interview to review and verify women's decision-
making experiences over time and to obtain additional
data regarding factors that influenced their decision mak-
ing. All telephone interviews were audio-taped and tran-
scribed verbatim.
We selected three cases to represent different decision out-
comes regarding RM among the women who tested posi-
tive for a BRCA1/2  gene mutation. Data from the
questionnaires and interview transcripts were analyzed.
Summative scores for study measures were calculated forBMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
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each time interval (see Table 1) and content analysis of
interview data was completed. The measures at the three
time points were evaluated to identify individual trends in
the decision-making process. These trends were then com-
pared to the qualitative data and a synthesis was devel-
oped to provide a detailed narrative of each woman's
decision-making trajectory. Minor changes have been
made to the details of each case to maintain participants'
confidentiality (e.g. we do not identify whether they had
a BRCA1 or BRCA2 gene mutation, and have modified
their family histories) and permission to report each case
was obtained.
Results
A description of each woman's decision-making experi-
ences is presented to reflect their narratives and the con-
text in which their decisions were embedded.
Case #1
This 40-year-old healthy woman began to think about RM
after she received a positive BRCA genetic test result. She
had attended genetic counselling several months earlier
with her sister, who also received the same result.
Although RM was presented as one of the options to con-
sider during her genetic counselling sessions, it was at her
first high-risk screening clinic appointment, several weeks
after receiving her test result, that she requested more
information about RM and was given the RM booklet.
Breast cancer was not an unfamiliar event for this woman.
Her mother, one aunt, two maternal great-aunts and two
of her mother's cousins had all been diagnosed with
breast cancer, and several friends had received cancer diag-
noses at young ages. After her mother's breast cancer diag-
nosis eight years earlier, this woman stopped doing
regular breast self-examinations, because she felt too anx-
ious about the likelihood of finding a lump. She admitted
that worry about breast cancer strongly affected her ability
to perform daily activities even though none of her close
female relatives affected by breast cancer had died of their
disease. At baseline, she perceived her knowledge of breast
cancer screening and RM to be low, and she reported a
moderate level of decision conflict (see Table 1).
In her follow-up consultation, two months after receipt of
the RM booklet, she stated that when she first learned
about RM, she felt that she "didn't have a choice," and
was, therefore, leaning towards having RM. After "lots of
thinking about it" and searching out information, she
learned that surgical removal of her ovaries would "free
her" from the worry of ovarian cancer, which is associated
with carrying a BRCA gene mutation, and also reduce her
risk of breast cancer. She decided that undergoing an
oophorectomy (and hysterectomy) was the "first step, the
smartest step" and represented an option that was "less
radical" and "made much more sense" for her than having
her breasts removed. Because this woman had a history of
Table 1: Participants' knowledge and decision measures related to risk-reducing mastectomy (RM) at follow-up intervals
Case #1 Case #2 Case #3
Measure Baseline 1st Follow-
up
2nd Follow-
up
Baseline 1st Follow-
up
2nd Follow-
up
Baseline 1st Follow-
up
2nd Follow-
up
Knowledge score1 6/10 8/10 9/10 9/10 9/10 9/10 7/10 7/10 7/10
Perceived level of 
knowledge of RM2
5/10 6/10 8/10 7/10 5/10 5/10 7/10 7/10 9/10
Perceived level of 
knowledge of breast 
screening2
4/10 7/10 8/10 7/10 5/10 7/10 8/10 8/10 6/10
Decision conflict3 2.42 2.58 2.58 1.0 1.83 3.33 2.16 1.83 2.33
Confidence with 
decision making4
n/a 9.2 8.2 n/a 8.0 5.0 n/a 9.5 9.5
Decision status5 Leaning to 
RM
Leaning to 
RM
Decided no 
RM
Leaning to 
RM
Leaning to 
RM
Undecided Decided yes 
RM
Leaning to 
RM
Had RM
1Knowledge was measured using a series of ten true/false questions that were developed to assess women's knowledge about RM.
2Participants rated their perceived level of knowledge about RM and breast cancer screening on a ten point scale, where 1 is poor and 10 is 
excellent.
3Decision Conflict Scale [22,23] – A 12-item 5 point scale that assesses four areas of decision making: (uncertainty, feeling uninformed, clarity of 
values, and feeling unsupported). Scores may range from 1 (low decisional conflict) up to 5 (high decisional conflict).
4Confidence with Decision Making [24] – A 4-item 11 point scale that assesses level of confidence that advantages and disadvantages are 
understood, that a decision will be made, and of talking with health care providers about RM. Scores may range from 0 (not at all confident) to 10 
(completely confident).
5Decision status [23]: Participants were asked to select the one of the following statements that best described their current thoughts about RM: 
You have decided to have prophylactic mastectomy; You are leaning towards having prophylactic mastectomy, but have not made a final decision; 
You have not decided one way or the other about prophylactic mastectomy; You are leaning towards not having prophylactic mastectomy, but have 
not made a final decision; You have decided not to have prophylactic mastectomy.BMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
Page 4 of 9
(page number not for citation purposes)
painful menstrual cycles and already had children, she felt
that she "did not need" her uterus and ovaries anymore;
furthermore, she perceived the hysterectomy to be a deci-
sion with "internal" effects only.
Compared with risk-reducing oophorectomy and associ-
ated hysterectomy, thinking about RM resulted in far
more unanswered questions for this woman, especially
with regard to details of the surgery and breast reconstruc-
tion. She referred to RM as a "stage two option" that might
be taken in the future, whereas she viewed herself at "stage
one". The woman reflected on her approach to making a
decision about RM and said, "I think I have to do it in a
step process to know that this is absolutely what I have to
do." At this time, she described regular breast screening as
a pro-active step she could take to protect herself, and
wanted to find out how screening would affect her emo-
tional health over time.
Three months after the consultation, during the first fol-
low-up interview, she indicated she was still leaning
towards having RM, but had not made a final decision.
Her perceived knowledge of RM and breast screening had
increased slightly by this time, and her decision conflict
remained stable, but she scored extremely high on the
decision confidence scale. Six months later, at the second
follow-up interview, this woman talked convincingly
about her positive experience with oophorectomy/hyster-
ectomy some months earlier, and reported that she had
further modified her decision about RM. Confident that
removing her ovaries had "covered all her bases" in terms
of preventing cancer, she had decided not to have RM. At
this time, her perceived knowledge levels had again
increased slightly, her decision conflict was unchanged,
and her decision confidence remained high.
Reflecting on the shift in her decision making over time,
this woman stated that her initial reaction was made
"without really thinking it through" and that she now
realized that RM was "too radical" and that unlike ovarian
cancer, early detection methods were an effective strategy
for dealing with breast cancer risk. She reported that breast
self-exam was easier after her oophorectomy without as
much estrogen circulating in her body, and she believed
she would be able to detect a significant change in her
breasts, if one occurred, or that it would be found by the
high-risk breast cancer screening program in which she
was now participating.
When asked how the RM booklet had influenced her deci-
sion, she described the booklet as something that "helped
her a lot" in terms of organizing her thoughts, weighing
the pros and cons of each option, preparing her to make a
better decision, and ensuring that her time with doctors
ran "more smoothly." However, she also expressed a
desire for more information than was provided, especially
in the form of example case studies. When asked what
would be most helpful if she was to revisit her decision
about RM in the future, she identified, as a priority, the
opportunity to speak with women who had experienced
RM firsthand.
Her reflection on decision making about RM illustrates
her increasing uncertainty and the unexpected complexity
of this decision:
I think that it's something that you really do have to think
long and hard about. Really have to look at all the risk fac-
tors. You have to have all the information in front of you.
Talk to your health care professional. Talk to your spouse
or whoever is important. It's not something that you can
just make a split decision and just, 'This is what I'm going
to do,' cause that's what I did initially and it's probably a
reaction that a lot of people have. 'That's it. I'm just going
to have them off, to do this. I've made the decision'. It's
not that easy of a decision. Something that you really have
to think about because this, it's big. It's a big surgery.
Case #2
This 49-year-old woman, who described herself as calm,
secure and relaxed, found that her decision about whether
to have RM became increasingly difficult over time.
Genetic testing by a relative with both breast and ovarian
cancer had identified a BRCA gene mutation in her family.
She pursued genetic testing after her mother, who had
recently been diagnosed with breast cancer, was found to
have the same gene mutation. Four months after receiving
her own positive result, this woman initiated a discussion
about RM during her appointment at the high-risk screen-
ing clinic and was given the RM booklet. Her baseline
scores showed that she perceived her knowledge about
breast cancer screening and RM to be relatively high, and
that she experienced no decision conflict (see Table 1).
She stated that she leaned strongly towards having RM
after she received her genetic test results and learned about
the surgical option.
At her consultation, two months after receipt of the RM
booklet, she expressed concerns about her tentative plan
to have risk-reducing oophorectomy, and appeared more
focused on this decision than on RM. She was particularly
worried about the after-effects of "instant menopause"
and raised issues about hormone replacement therapy,
quality of life, and associated health risks. Her sister expe-
rienced an extremely difficult time after undergoing hys-
terectomy (including oophorectomy), and she worried
that her quality of life might diminish as well. Although
she thought she would "go ahead" with the surgery, she
wanted to talk with other women who had already had
the procedure.BMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
Page 5 of 9
(page number not for citation purposes)
Nevertheless, at this time she maintained she was still
leaning towards having RM and was emphatic that she
was not concerned about losing her breasts and her repro-
ductive organs. She admitted, however, to feeling "too
nervous" to look at online photographs of breastless
women because they might be "too graphic". She raised
questions about breast reconstruction options and proce-
dures, and wanted to speak with women who could tell
her about the experience firsthand. When she shared
information about RM with her sisters and her mother,
she said they were "shocked" that she would seriously
consider such a "severe choice." One sister stated that she
had heard horror stories from women who had gone
through this surgery. The participant concluded that if she
decided to have RM, she would not be able to tell her fam-
ily about her decision until after the surgery.
At the first follow-up interview, she had already had her
oophorectomy/hysterectomy and was still considering
RM. Her decision conflict score related to RM was slightly
higher than her baseline score, while her perceived knowl-
edge levels had decreased (see Table 1). She maintained
that she was still leaning towards a decision to undergo
RM. Although she still had unanswered questions about
the effects of the surgery, her high decision confidence
score was indicative of her perceived ability to make a
decision about RM.
However, four months later at the second follow-up inter-
view, this woman described herself as "not decided one
way or the other about RM," and reported that she was
now less confident in her ability to make a decision, and
less confident that she understood the risks. Study meas-
ures showed that her decision conflict score had increased
again, while her decision confidence score had decreased,
and her perceived knowledge level scores remained at
moderate levels. She found that the decision became
increasingly difficult as she gathered more information
and developed new questions about breast reconstruc-
tion. She wondered about how her body would look with-
out breasts and after reconstruction, the possibility of scar
tissue build-up, the effect on her body if she elected to
have larger breasts constructed, and the longevity of
implants or reconstruction over time. She appeared to
have realized that she had not gathered all the informa-
tion she needed and she stated she might need to make
time to re-read the RM booklet to help clarify some of the
issues that had arisen for her.
One of the strongest factors influencing this woman's
decision making about RM was her disappointment with
the surgery she had to prevent ovarian cancer and reduce
her risk of breast cancer. The severe symptoms she experi-
enced afterwards, attributed to "the hormone battle"
caused by the surgical removal of her ovaries, prompted
her to begin using hormone replacement therapy (HRT),
a decision that she questioned because of links between
HRT and breast cancer. She realized that she did not have
sufficient information about the implications of her first
surgery and that there might have been other options she
could have considered. She seemed determined to not let
this happen again with other decisions, particularly RM.
The inconsistent medical advice regarding RM (and also
HRT) provided to her, her sister and her mother (each liv-
ing in a different province) increased her confusion and
indecision, and left her feeling angry and frustrated.
The fact that no one in her family had died from breast or
ovarian cancer seemed to add to this woman's indecision
about RM. Because her mother's breast cancer was diag-
nosed at an older age and she thought it was caused by
long-term use of HRT, this woman did not currently per-
ceive her own breast cancer risk to be extremely high,
despite her genetic test results. She worried about how her
body would look following breast removal and about
scarring that would be left. Reflecting on the course of her
decision making and the importance of information, she
remarked:
It has gotten more and more difficult, [whereas] at the
very beginning it just seemed like a no-brainer... I'm still
not clear about how many surgeries and I'm still not, and
when I say clear, it's not perfectly clear about the skin. I
thought that I had the implants at the time of the surgery
but it sounds like you don't. It sounds like you have to
have the skin extenders in and then go back a second time
for the implants. All that kind of stuff, it's not really clear
to me.... I'm not complaining or anything like that. But
I'm just saying it's a very difficult situation, there's just not
enough information out there, long term.
She decided that she needed to go back and speak with the
surgeon again. In the meantime, she was committed to
participating in regular breast screening to provide the
reassurance she needed while putting the decision about
RM "on the back burner" Her indication that she was
more inclined to withstand the surgery rather than risk
ever being told she has cancer, suggests that this decision
would not be put aside for the long term.
Case #3
This 59-year-old woman had an extensive history of breast
cancer on both sides of her large family, with two sisters,
two aunts and four cousins having been diagnosed with
the disease. Not surprisingly, worry about breast cancer
affected her mood "a lot." Five months after she received
positive BRCA  gene test results, she felt ready to "take
action" and received the RM booklet on the suggestion of
her sister, who was aware of her plans to undergo both RM
and risk-reducing oophorectomy. This woman stated thatBMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
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her initial decision was to have her breasts removed, and
although she never completely changed her mind, post-
operative complications from her oophorectomy created
additional doubts and it became difficult for her to final-
ize a decision about RM. She wondered when, and if, she
would be ready to undergo another surgery. At baseline,
she perceived her knowledge of breast cancer screening
and RM to be good and she reported a moderate level of
decision conflict (see Table 1).
At her consultation, two months after receiving the RM
booklet and a week after oophorectomy surgery, she
stated, "I can't honestly say that I'm not scared...but I
really feel in my heart that it's [RM] the right decision." At
the first follow-up interview, she reported that the booklet
helped her "a great deal" to organize her thoughts about
this decision, consider the pros and cons of RM, and iden-
tify the questions she needed to ask. In interactions with
family, friends and doctors, she sought opinions and
gauged their reactions to assist her in finalizing her deci-
sion. Turning to health care professionals for advice, she
found they would not weigh-in on the decision. She
described how she repeatedly attempted to gain the per-
sonal opinion of health care providers and how a "slip" by
one oncologist was interpreted as approval to go forward
with surgery. She found this to be reassuring. The breast
cancer experiences of two sisters, one of whom died of her
cancer, were also influential in her decision about RM.
Although both sisters participated in breast screening,
their tumours were identified between their regular mam-
mograms. This woman did not want to risk being diag-
nosed with breast cancer later in life or regret not having
done everything she could to prevent it.
At the second follow-up interview three months later, this
woman confirmed she had undergone RM, one month
earlier. She stated that "even up to the very end I was say-
ing, oh my God, oh my God." She recalled that she re-read
or referred to all the sections of the RM booklet in the
months preceding surgery. When she accepted the RM sur-
gery date, she described still feeling unsettled about the
decision until her husband "cleared the air" for her. He
had left the RM decision to her, but when she mentioned
to him that she might not go through with the surgery, he
told her: "Maybe you have to look at this as something you
have to do for your health." After hearing this, she recalled,
"I knew absolutely that day, that the decision I was mak-
ing was the right decision for me." Reassured that her
adult children and surgeons also believed her decision to
be a good one for her situation, she had felt ready to go
forward with the surgery.
Although she acknowledged that the process had not been
easy, she expressed definite satisfaction with the decision
after the surgery was complete. Throughout the decision-
making process, her decision confidence score remained
very high, her decision conflict score remained consist-
ently moderate, her perceived knowledge of RM score
steadily increased and her perceived knowledge of breast
cancer screening decreased (see Table 1). She described
the immediate after-effects of the RM as "amazing," feel-
ing as though "a load was off my mind". She stated that
this was the first time since her sister was diagnosed with
breast cancer five years earlier that she was able to feel
carefree about life.
Although ultimately deciding to have RM, she highlights
the difficulties of her decision making in the following
way:
It was just the thought of, was I doing something need-
lessly. And was I being selfish, in wanting to, let's say okay,
not me, you know. It was just simply making the decision,
that was just, it was just. At first I thought it was pretty easy
to say 'Well okay I have some options here now', and one
of the ones is I can have prophylactic mastectomy. And I
just thought that was a more definite thing, and, uh, the
most challenging thing to me was that nobody would tell
me, nobody would tell me what to do. Like, I ultimately
had to make the decision myself. That was the most chal-
lenging I think.
Discussion
The experiences described in this study represent three dif-
ferent RM decision outcomes by three healthy women
who carry a BRCA1/2 gene mutation, received the RM
information booklet to support their decision making,
and were initially leaning towards RM. Case #1 decided
against RM; over the course of a year, she clarified her val-
ues, gathered information, and changed her initial deci-
sion. Case #2 remained undecided about whether to have
RM. As she gathered more information over the year, she
became more ambivalent about RM. Case #3 proceeded
with RM, despite several months of increasing doubt after
making that decision. She searched for reassurance and
encouragement to proceed with surgery, before confirm-
ing her decision.
The women represented by these cases demonstrate three
different decision-making processes related to the option
of RM and underline the importance of time in that proc-
ess. Each woman felt she was leaning towards RM when
first informed about the surgical option near the time of
receiving her genetic test results. Those initial thoughts
about RM, however, evolved over the course of follow-up,
which ranged from eight to twelve months. For these three
women, it appeared important to take time to make an
informed decision about RM, one that they could live
with comfortably, that reflected their own needs and val-
ues, and that was based on a good knowledge of the risksBMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
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and benefits of surgery and the effectiveness of other can-
cer risk-reducing strategies. Although the comprehensive,
longitudinal data collected in this prospective study pro-
vided a rich, detailed description of each woman's experi-
ence, which was verified by each participant, we recognize
that there may be other RM decision-making experiences
that are not represented by this case series.
Women who live with a BRCA1/2 gene mutation face a
difficult and complex decision regarding RM, and these
three cases highlight some of the challenges inherent in
this decision. All three women focused strongly on quality
of life issues, specifically the risk of decreased quality of
life (i.e., associated with the impact of surgery on their
physical health, body image and relationships) versus the
benefit of a significant reduction in breast cancer risk. Lit-
tle research exists that addresses the quality of life issues
for women who have undergone RM [15]. Struggling with
uncertainties, these women spent much time reviewing
the study RM booklet as well as locating additional
sources of information in an attempt to resolve their own
questions about the impact of RM on their lives. In some
instances, the uncovering of new information raised new
concerns; for example, learning more about breast recon-
struction generated questions for Case #2 about the com-
parative risks and details of the different surgical choices.
Hallowell has observed that health care providers
approach discussions with women about RM differently
than other cancer risk management choices [16]. The
women participating in our study consistently expressed
frustration when their interactions with health care pro-
viders failed to yield specific recommendations. They
wanted a response from health care providers as to the
appropriateness of their decision in light of their cancer
risk. Women's uncertainty in the decision-making process
was heightened when providers indicated that RM is a
woman's personal decision. On the other hand, while
women looked for medical reinforcement of their deci-
sions, when a health care provider indicated an opinion
that was not in line with one woman's beliefs, this situa-
tion became an additional source of frustration. Further
research is needed about the consequences of health care
providers offering advice related to RM while at the same
time supporting autonomous decision making.
Few studies in the literature address the nature and char-
acteristics of the RM decision-making process in terms of
time or the importance of decision support. Two studies
that utilized an intervention, either a decision aid or indi-
vidual survival curves as part of a decision support system,
showed improvement in satisfaction with the decision but
did not assess changes in the decision over time [11,12].
In the three cases reported here, initial decisions were
reviewed and revised several times over a period of six
months to a year before a "final" decision was made. The
extent to which this extended decision-making process is
a by-product of the health care system in Canada in which
lengthy wait times exist for elective surgeries such as RM,
or is intrinsic to an irreversible and life-altering surgery
decision, is unknown. The paucity of research on psycho-
logical consequences of RM and decision-making proc-
esses was noted by the authors of a Swedish study of 56
women at high risk for familial breast cancer and consid-
ering RM [17]. They reported that the process of reaching
a decision about RM took about one year to enable the
women to reflect adequately on their options. Interest-
ingly, 91% of the women elected to undergo RM (however
16 of these women had previously been affected with
breast cancer). These women decided about RM after they
received a collaborative recommendation from a multi-
disciplinary team that included geneticists, oncologists,
breast surgeon, plastic surgeon, nurses and a psychologist.
At 2-year follow-up, the majority of women in this study
expressed satisfaction with the procedure. While cultural
differences may account the for the high rate of acceptance
of RM in the Swedish study, the strong level of integrated
decision support stands in contrast to the experiences of
women in our study.
In a Dutch study, 51% of unaffected female BRCA1/2 gene
mutation carriers elected to have RM, with 89% of these
women making their decision within nine months of
receiving their genetic testing results [18]. These authors
focused on the importance of counselling and the benefit
of reduced fear in reducing the likelihood of decision
regret, and did not address the time women may need to
fully weigh the issues involved in RM. Again, it is difficult
to separate out any cultural contribution that may account
for the Dutch results, however, all three of our cases ini-
tially reported being in favour of RM and yet as they
became more informed and gathered more information
and opinions and about this surgical option, their deci-
sions changed.
High-risk women considering RM as a strategy to reduce
breast cancer risk, and thereby reduce fear, have been
characterized largely as a homogenous group defined by
the results of their genetic test. Other researchers have
investigated women with family histories of breast and
ovarian cancer using the concept of "chronic risk", to
focus on the ongoing adaptation that occurs in the lives of
women with heightened cancer risk perception [19,20].
Results suggest that perceptions of heightened risk and
associated decisions fluctuate over time, increasing or
decreasing, depending on life events and experiences,
such as reaching the age when close family members were
diagnosed with cancer in the past, friends or family mem-
bers developing cancer, life stage in terms of child-bearingBMC Women's Health 2007, 7:3 http://www.biomedcentral.com/1472-6874/7/3
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and child-rearing, and experiences with false positive
results of cancer screening tests [20].
A staged or phased model of coming to terms with one's
personal perception of risk has been identified and
described by Chalmers and Thomson [19]. Their qualita-
tive research with women at high risk for developing
breast cancer revealed three interdependent phases that
included living the cancer experience, developing a risk
perspective, and putting risk in its place. Women were
found to integrate the knowledge of being at risk into their
self-identity by being either a "controlling woman" or
"non-controlling woman". A controlling woman is more
likely to make dietary changes and participate in screening
and breast self-exam, whereas a non-controlling woman is
less likely to adopt lifestyle changes and expresses a more
fatalistic view concerning cancer. "Putting risk in its place"
did not occur for all women, and was not a static process,
indicating that some women are more able to live with the
perception of chronic breast cancer risk than others. Press
et al [21] argued that RM may have different meanings for
women, and they explained the variation in women's
uptake of RM in the United States, in terms of the distinc-
tion between illness and disease. Women who see RM as
mimicking the illness of breast cancer, as opposed to pre-
venting the disease, are less likely to consider the proce-
dure an option. They also point out that because actual
uptake of RM is higher in several international studies
than any reported hypothetical interest in the surgery, it is
important to gain a better understanding of how women
perceive RM.
Conclusion
Given the lack of available research that has examined
women's decision-making processes and the psychologi-
cal and medical outcomes of RM, it may be wise for health
care providers to view the decision-making process as
fluid and one that may involve extended or recursive proc-
esses, dependent on women's psychological coping style,
values, life experiences and circumstances. Women with a
BRCA1/2 gene mutation may choose to revisit the RM
decision at different stages of their lives and, therefore,
require long-term professional support in a decision-mak-
ing process that is contextualized by medical uncertainty
and a lack of conclusive information. Longitudinal studies
that investigate RM decision-making outcomes over time
are needed to understand how best to support women in
this decision-making process.
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